Schedule 13D ownership disclosure

ADAMAS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00548A106

Event date: 2014-04-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
27.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001188112-14-001121
Form type
SC 13D
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Apr 25, 2014
Reporting period
Apr 15, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub

SC 13D | SEC Filings Hub